|
|
|
|
|
|
Sponsored by: |
Radboud University |
Information provided by: | Radboud University |
ClinicalTrials.gov Identifier: | NCT00523263 |
Clinical trial for the comparison of long-term patency of heparin-bonded Dacron and human umbilical vein vascular prostheses in above-knee femoro-popliteal bypass surgery.
Condition | Intervention | Phase |
Intermittent Claudication Arterial Occlusive Diseases Atheroslerosis |
Device: heparin-bonded and collagen coated polyster Device: Human umbilical vein femoro-popliteal bypass |
Phase III |
ChemIDplus related topics: | Heparin |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study |
Official Title: | Heparin Bonded and Collagen Coated Polyester or Human Umbilical Vein for Femoropopliteal Bypass: a Prospective Randomised Multicentre Trial. |
Study Start Date: | January 1996 |
Study Completion Date: | April 2007 |
Arms | Assigned Interventions |
Dacron: Active Comparator
Patients receiving polyester above-knee femoro-popliteal bypass
|
Device: heparin-bonded and collagen coated polyster
femoro-popliteal bypass
|
HUV: Active Comparator
patients receiving HUV femoro-popliteal bypass
|
Device: Human umbilical vein femoro-popliteal bypass |
Ages Eligible for Study: | 31 Years to 89 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Netherlands | |||||
Radboud UMCN, Dept Vascular Surgery | |||||
Nijmegen, Netherlands, 6500 HB |
Radboud University |
Principal Investigator: | J. Adam van der Vliet, MD, PhD | Radboud University Medical Center Nijmegen |
Study ID Numbers: | DaDa-trial |
First Received: | August 30, 2007 |
Last Updated: | August 30, 2007 |
ClinicalTrials.gov Identifier: | NCT00523263 |
Health Authority: | Netherlands: Medical Ethics Review Committee (METC) |
|
|
|
|